The ability of porous bodies to distinguish between molecules of different sizes has been repeatedly observed. If these porous bodies are devoid of charged groups, solutes placed on top of a column filled with such a material will be partitioned chiefly by molecular sieve effect (1) . Molecules with a size above a limiting value will leave the column immediately after the displacement volume. Smaller particles will enter the gel grains and will be retarded and eventually separated into groups of different molecular weight. Such columns, on the other hand, may perform an exhaustive dialysis. The use of dextran gels for these purposes was introduced by Porath and Flodin (2) ; as suggested by Tiselius the method was named gel filtration.
Nonmetabolized corticoids may be found in human plasma in three different forms: a very small fraction of unbound steroids, a fraction weakly bound to albumin, and a fraction strongly but reversibly bound (3) to a specific protein called transcortin (4) . Under basal conditions the latter fraction represents 95 to 98 per cent of total plasma cortisol.1 * This investigation was supported in part by Grant no. 173 from the Nationaal Fonds voor Geneeskundig Wetenschappelijk Onderzoek, Belgium. 1 The following abbreviations have been employed: corti sol (1 18, 17a,21 -trihydroxy-4 -pregnene-3,20-dione); cortisone (177a,21 -dihydroxy -4 -pregnene -3,11,20 -trione) corticosterone (1 1,,21-dihydroxy-4-pregnene-3, 20-dione); testosterone (17,8 - hydroxy-4-androstene-3-one) ; deoxycorticosterone (21-hydroxy-4-pregnene-3,20-dione); progesterone (4-pregnene-3,20-dione); compound S (17Ya,21-dihydroxy-4-pregnene-3,20-dione); androsterone (3a-hydroxy-androstan-17-one); 17-hydroxyprogesterone (17a-hydroxy-4-pregnene-3,20-dione); tetrahydro-S (3a,17a,21-trihydroxypregnane-20-one); pregnanediol (pregnane-3a, 20cx-diol) ; pregnanetriol (pregnane-3a,17a,20a-triol) ; tetrahydro-DOC (3a,21-dihydroxy-pregnane-20-one); A0-pregnenolone (3p-hydroxy-5-pregnene-20-one); dehydroepiandrosterone (3p8-hydroxy-5-androstene-1 7-one); ethynylUsing gel filtration, the binding of corticoids to plasma proteins could be studied, excluding the albumin binding. The presence of a macromolecular agent strongly binding corticoids was also demonstrated in other biological material. The bound corticoids were quantitated fluorometrically as well as by radioactivity measurements.
MATERIALS AND METHODS
The procedures used for preparation of the dextran gels, packing of the columns, application of the sample, and elution were as described by Flodin (1) . Elimination of the "fines" is essential in order to avoid clogging of the columns. Three different gels (Sephadex G-25, Sephadex G-50, and Sephadex DEAE A-50 2) were tried with good results; in the experiments to be described only Sephadex G-50 was used. Figure 1 shows the type of results obtained.
In a preliminary study conditions were considered, which could eventually in the course of gel filtration affect decomposition of the protein-steroid complex by dialysis effect, or alter the separation of the proteinbound and unbound corticoids. As far as the former effect (i.e., decomposition) is concerned, temperature and elution rate were found to be important. To assess the influence of temperature, 1-ml plasma samples were "overloaded" with 500 mpug of cortisol and preincubated for 15 minutes at the desired temperature. At 4°C runs were made in a cold room, whereas at 340 C and at higher temperatures columns with a jacket connected to a thermostat were used. From 4°to 340 C there was an almost linear decrease of the amount of steroids in the protein peak. At the latter temperature the mean binding was 28 per cent lower than at 4°C. At a somewhat higher temperature the binding abruptly fell to very low values ( Figure 2 ). This extreme lowering proved to be reversible (4 In the eluted fractions, as in the original plasma samples, corticoids were determined with a fluorometric procedure (5, 6) and total protein according to a technique described by Lowry, Rosebrough, Farr and Randall (7), in which a purified a-lactoglobulin was used as a standard. The NaOH wash, normally included in the fluorometric procedure, is not necessary after gel filtration of plasma samples of male patients. In female patients, however, the results were higher when the wash was omitted, and the NaOH step was therefore retained in the routine procedure.
The displacement volume of the columns is about 9 ml and can be estimated visually. During standardization of the method the effluent collected thereafter was examined in 2-ml fractions. The plasma proteins put on top of the gel bed were always found in the first 6 to ally, the latter fraction contains more than 0.8 ,Ag per 100 ml of cortisol equivalents, the column and the gel filtration experiment are discarded. After another 4 ml of buffer eluent was added, the unbound corticoids (small molecules) finally came off the column. Once prepared, a column can be used 50 to 100 times before clogging. After each run it is washed with 40 to 50 ml of eluent and stored well-stoppered at room temperature. Very similar results were obtained in four duplicate determinations with old and freshly prepared columns.
When the test is done without in vitro addition of corticoids, the amount of corticoids found in the protein fraction is called the spontaneous protein-binding fraction. The latter parameter can be expressed in micrograms of endogenous corticoids bound per 100 ml of plasma or per gram of protein, and also as percentage of the unconjugated corticoid level. After overloading and equilibration (at least 15 minutes) with cortisol, the amount of corticoids found in the protein fraction is defined as the binding capacity. This parameter is independent of the unconjugated plasma corticoid level and is expressed in micrograms of corticoids bound per 100 ml of plasma or per gram of protein.
Heparinized plasmas were obtained at given times of day, from patients hospitalized in the Department of Internal Medicine. Subjects with endocrinological disorders or who had been treated previously with ACTH or corticoids were eliminated from the control ("normal") series; patients with kidney or liver diseases or with hypertension were also excluded. Infusions of ACTH, catecholamines, or corticoids were performed in certain subjects according to methods described previously (8) . Corticoid-poor plasma was obtained by sampling blood at 12 p.m. from "normal" subjects; it was considered adequate when the unconjugated plasma corticoid level was about 5 ,tg per 100 ml fluorescent cortisol equivalents. Erythrocytes were washed six times with isotonic glucose solution. After hemolysis with an equal volume of water and filtration on Whatman no. 1 paper, the mixture was subjected to gel filtration with or without added cortisol or corticosterone (500 m/ug per ml).
Pleural, spinal, and ascitic fluids were collected in heparinized tubes. Fresh urine samples were used as collected. Plasma protein fractions were prepared by classical salting-out and electrophoretic techniques (9) . Rechromatographed, tritium-labeled steroids were used in certain experiments; the fractions collected were counted in an automatic liquid scintillation spectrometer (Tri-Carb, Packard Instrument Co.).
RESULTS
Reliability of the routine method. The method described meets the criteria put forward by Borth (10) . The precision of the cortisol-binding capacity assay can be estimated from the standard deviation between simultaneous and random duplicate determinations. The relative standard de- (Table I) . This is another check of the specificity of the procedure.
In a second set of experiments, corticoid-poor plasma was overloaded with equal amounts of cortisol and another steroid (competition). After 15 minutes of incubation, gel filtration was per- In the course of pregnancy a marked increase of the cortisol-binding capacity was noted from the second month on. Four subjects in the second month of pregnancy had a mean cortisolbinding capacity of 39.4 ,ug per 100 ml; 5 subjects in the third month 42.2; 2 subjects in the fourth month 48.4; 2 subjects in the fifth month 52.4; 6 subjects in the sixth month 44.8; 5 subjects in the seventh month 56.2, and 6 subjects in the eighth month 52.4 pg per 100 ml. Six normal males received either two daily doses of 5 mg stilbestrol (2 subjects) or two doses of 0.5 mg ethynyl-estradiol (4 subjects) for 7 days. The 8 a.m. unconjugated corticoids and the cortisol-binding capacity were determined daily. The transcortin-binding capacity rose more rapidly than the unconjugated corticoid level (Figure 3) . The spontaneous bind- 
FIG. 4. ABSENCE OF DIURNAL VARIATION IN THE CORTISOL-BINDING CAPACITY OF HUMAN PLASMA (30 EXPERIMENTS).
ing (not shown in Figure 3 ) followed the unconjugated corticoid level and remained at a normal 93 per cent of this level. Plasma cortisol-binding capacity did not show any diurnal variation (Figure 4 ). Patients whose adrenocortical production had been acutely or chronically suppressed with artificial nonfluorescent steroids (prednisone, prednisolone, triamcinolone or dexamethasone) had a normal cortisolbinding capacity 10 hours after the last peroral administration of the steroid medication. During steroid medication or in the first hours after an intravenous injection of 25 mg prednisolone sodium succinate, an apparent lowering (up to 30 per cent) of the cortisol-binding capacity occurred, possibly caused by competition for the binding sites. The cortisol-binding capacity was not influenced either in males or in females given intravenous infusions of ACTH with or without added catecholamines ( Figure 5 ). Cortisol injected in pharmacological doses in six subjects did not alter the binding capacity in the next 6 hours ( Figure  6 ). Two normal subjects given 2 g of acetylsalicylic acid every Figure 7 . Of interest are the low values found in some uncomplicated cases of obesity with low unconjugated 8 a.m. plasma corticoid levels but normal total plasma proteins. Low levels, on the other hand, were noted in some patients with hypoproteinemia caused by cachexia, hepatic or renal disease, and also in one patient with multiple myeloma. High values were found in some other patients with liver disease and in some patients with pulmonary tuberculosis (mean, 27. 1 fig per 100 ml) . Normal results were obtained in 26 patients with hypertension (26.8 ug per 100 ml), in 19 patients with diabetes mellitus (25.5 jug per 100 ml), and in 6 patients whose blood was taken immediately and again 2 days after extensive abdominal surgery. Comparative study of the cortisol-binding capacity of plasma of various animals. Heparinized blood was taken from various animals, and the cortisol-binding capacity determined. The values obtained were compared with figures found in the literature for the unconjugated plasma corticoid level of the unstressed animal and also for the biological half-life of cortisol injected in pharmacological doses (Table IV) .
Cortisol-binding capacity of red blood cells. In ten experiments with filtered erythrocyte hemolysates, a mean binding capacity of 0.38 ,ug of cortisol and 0.41 pg of corticosterone per g of protein was found. (16, 17) * Experimental data reported in this paper; [ ] number of subjects.
t Data from the literature; ( ) reference number.
DISCUSSION
Gel filtration makes it possible to isolate from plasma and other biological fluids a corticoid fraction, which is strongly bound to macromolecular material. In plasma only a-globulin preparations can bind cortisol when overloaded with the hormone and passed through Sephadex columns. These a-globulin preparations can be further purified by ammonium sulfate precipitation. As far as can be inferred from the results obtained hitherto, the latter protein preparations show a physicochemical behavior that is consistent with descriptions of transcortin given in the literature (19) . The protein-bound corticoids eluted from the columns proved to be a close estimate of the amount of transcortin-bound corticoids in the plasma sample examined.
The latter affirmation might seem preposterous as one would expect the transcortin-corticoid complex to dissociate continuously by passing through a gel bed devoid of unbound steroid. This exhaustive dialysis effect, however, proved to be unimportant in the case of cortisol and corticosterone, as shown by the clear-cut separation without detectable tailing obtained with these steroids. One would expect this, since it is known that the affinity constant(s) of the transcortin-corticoid binding reaction is very high and that the experimental conditions were set so as to minimize the exhaustive dialysis effect. That some dissociation does indeed occur is shown by the increase of the binding capacity obtained by increasing the elution rate from 0.5 to 2.5 ml per minute and the 93.4 per cent spontaneous binding found in plasma, whereas about 96 per cent binding was to be expected at room temperature. Still better estimation of the bound corticoids could probably be obtained by using somewhat greater elution rates with shorter columns at 40 C. This, however, seemed neither practical nor necessary.
Most current methods for measuring transcortin activity are based on equilibrium dialysis and the use of radioactive steroids. Gel filtration requires no isotopic steroids; being essentially dynamic, only strongly bound corticoids can be separated, but, by the same effect, interference by weakly bound steroids will be largely avoided. In contrast to the relative percentage data obtained by most other methods, the results here can be easily expressed in micrograms per 100 ml of plasma. Increases as well as decreases in binding capacity can be determined, whereas this is difficult with the equilibrium dialysis technique (20) .
The parameters defined here must be distinguished from most of those in the literature. Only Upton and Bondy (21) have used a comparable expression to quantitate transcortin activity.
Slaunwhite and Sandberg (4, 22) call transcortin binding the percentage of C14-cortisol bound by 10 ml diluted plasma after equilibrium dialysis. Binding capacity is defined as the decrease of C14-cortisol binding caused by addition of 1 ,ig of nonisotopic cortisol to the approximately 0.3 jug of isotopic hormone used to study transcortin binding. Daughaday (23) defines the combining capacity as the proportion of bound to unbound steroid X protein concentration (in milligrams per milliliter) in the bag after dialysis. In a later paper (20) a double dialysis technique is described and the relative binding activity defined as the amount of bound hormone in the test plasma divided by that in the control sample. In our paper, binding capacity gives a close estimate of the actual amount of steroid which can be bound under "overloaded" conditions per volume of plasma or per weight unit of protein.
According to the literature (20, 24) , saturation of transcortin with corticoids must occur at levels of 20 to 30 /Ag per 100 ml of plasma. The mean cortisol-binding capacity of 25.9 + 3.8 jug per 100 ml obtained with gel filtration is in line with this. As suggested by others (22) , no significant difference was found between normal males and females or between adults of different age groups (15 to 60 years). The low values noted in umbilical cord blood, and in certain patients with hypoalbuminemia and multiple myeloma, as well as the high ones induced by estrogen impregnation have also been reported already (20, 22, 24) . As noted by Sandberg, Slaunwhite and Carter (24) , the rise in cortisol-binding capacity induced by estrogen treatment precedes the elevation of unconjugated plasma corticoids. The effect of temperature on transcortin binding described by several authors (e.g. 20) could also be reproduced in gel filtration experiments. The binding capacity of plasma was not altered by the administration of pharmacological doses of cortisol. This binding capacity also remained unchanged during and after ACTH infusion. Since the unconjugated plasma corticoid level under these circumstances exceeds the transcortin capacity, it is clear that the capacity to bind added labeled steroid will be greatly decreased. This explains the results obtained by Sandberg and associates (24) . The same results were noted when catecholamines were added to the ACTH infusion. A change in transcortin activity thus cannot explain why the combined administration of ACTH and catecholamines in males produces a much smaller increase of unconjugated plasma corticoids than does the infusion of ACTH alone (8, 25) . Neither was transcortin capacity altered after extensive surgery.
Some new information about transcortin has also been gathered. The binding capacity for cortisol remains unchanged during the day, which would mean that the diurnal variation of the unconjugated plasma corticoids is not due to variations in transcortin capacity. The marked decrease in binding capacity observed in some patients with uncomplicated obesity, who also showed a low morning plasma corticoid level, shed new light on the findings of Szenas and Pattee (12) . This lowering could be apparent only if transcortin were saturated with abnormal steroids. This mechanism of partial saturation with steroids other than cortisol and corticosterone probably also explains why low cortisol-binding capacities were found during but not after the administration of artificial nonfluorescent steroids.
Some relation seems to exist between the unstressed plasma level of unconjugated corticoids on the one hand, and the cortisol binding capacity and the biological half-life of cortisol injected in pharmacological doses on the other. This was found to be so when blood was taken at 12 p.m. in normal subjects, in patients with obesity, and in various animal species. One might speculate that transcortin binding interferes with liver catabolism (24) and in this way determines the unconjugated plasma corticoid level in the unstressed individual.
In order to study capacity and affinity of plasma to bind steroids other than cortisol and corticosterone, corticoid-poor plasma was taken; thus comparable results could be expected. Even so, the presence of a small amount of endogenous cortisol and corticosterone has to be taken into account. Care was also taken to work under conditions of overloading (at least 200 m~ug per ml).
Cortisol and corticosterone are bound in comparable amounts. In the near absence of the latter steroids some other steroids can be bound in fair amounts (Table I ). The affinity of the binding plasma protein for most of those steroids is definitely smaller than that for cortisol or corticosterone, as can be inferred from the displacement experiments (Table II) . Only 17-hvdroxyprogesterone and compound S displace about 50 per cent of the cortisol and, thus, most probably have an affinity for transcortin equal to that of cortisol or corticosterone. Tetrahydro compounds, on the other hand, have less affinity for transcortin than their respective parent steroids. Analogous studies have been reported previously (4. 23. 24).
SUMM ARY
Gel filtration has been introduced to study protein binding of corticoids (cortisol and corticosterone) and related steroids. A method was devised, which proved to be efficient, accurate, and specific, and which makes it possible to determine, in 1 ml of plasma and without radioactive steroids, the spontaneous binding of corticoids on transcortin and the binding capacity of the latter protein fraction after cortisol "overloading."
The protein moiety of the isolated complex is a fast a,-globulin with physicochemical properties similar to those attributed to transcortin. Other plasma protein fractions do not bind cortisol in the given circumstances. In native plasmas 92.2 per cent of the steroid moiety of the transcortin complex is either cortisol or corticosterone. In the absence of the latter, other steroids can be bound in almost identical amounts, albeit less strongly.
The cortisol-binding capacity of plasma is the same in male and female adults between 15 and 60 years, the mean value being 25.9 + 3.8 (SD) jLg of cortisol per 100 ml of plasma. There is no diurnal variation, and during or after infusions of cortisol or ACTH no changes in binding capacity, as measured by gel filtration, were found. Low values of binding after cortisol overloading were noted in umbilical cord blood, in patients with hypoproteinemia, in patients treated with high doses of other steroids, and in some cases of uncomplicated obesity; high values were found in some cases of liver disease and pulmonary tuberculosis or after estrogen impregnation.
Transcortin-like binding could also be demonstrated in ascitic, pleural, and spinal fluid, but not in urine. In washed erythrocytes cortisol and corticosterone binding of strong affinity was present, although the capacity per unit weight of protein was much lower than in human plasma.
